Pancreatic cancer arises from activating mutations in oncogenic Kras, and the majority (90%) of human pancreatic tumors develop sporadically from cells carrying KRAS mutations;20 however, KRasG12D mutations alone are insufficient to drive malignancy.21 This evidence concerns the gene KRAS and pancreatic neoplasm.